REQUEST A DEMO
Total
USD $0.00
Search more companies

Bio-Fd&C Co.,Ltd. (South Korea)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Bio-Fd&C Co.,Ltd. Profile Updated: June 19, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Bio-Fd&C Co.,Ltd. is an enterprise in South Korea, with the main office in Incheon. The enterprise operates in the Medicinal and Botanical Manufacturing industry. It was incorporated on November 11, 2005. 65 (2023) employees currently work for Bio-Fd&C Co.,Ltd.. The company’s latest financial report indicates a net sales revenue increase of 32.43% in 2022. Over the same period, its total assets grew by 156.23%. Bio-Fd&C Co.,Ltd.’s net profit margin increased by 3.05% in 2022.

Headquarters
A-509~512,30,Songdommirae-Ro, Yeonsu-Gu
Incheon; Incheon;

Contact Details: Purchase the Bio-Fd&C Co.,Ltd. report to view the information.

Website: http://www.biofdnc.com

Basic Information
Total Employees:
Purchase the Bio-Fd&C Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Bio-Fd&C Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Bio-Fd&C Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Bio-Fd&C Co.,Ltd. report to view the information.
Incorporation Date:
November 11, 2005
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Company Performance
Financial values in the chart are available after Bio-Fd&C Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
32.43%
Total Operating Revenue
32.43%
Operating Profit
55.56%
EBITDA
57.55%
Net Profit/Loss for the Period
49.1%
Total Assets
156.23%
Total Equity
233.55%
Operating Profit Margin
4.57%
Net Profit Margin
3.05%
Return on Equity (ROE)
-10.13%
Debt / Equity
-4851%
Quick Ratio
6063.16%
Cash Ratio
1.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?